Європейський Союз - ісландська - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Європейський Союз - ісландська - EMA (European Medicines Agency)

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - aprepitantum inn - hart hylki - 125 mg/80 mg

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - desfluranum inn - innöndunargufa, gegndreyptur stabbi

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - paroxetinum hýdróklóríð - filmuhúðuð tafla - 20 mg

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 150 mg

Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - fluconazolum inn - hart hylki - 150 mg